Navigation Links
Unigene Reports Third Quarter 2011 Financial Results
Date:11/9/2011

ence call and live audio webcast today, November 9, 2011 at 11 a.m., ET to discuss the third quarter 2011 results.

Interested participants and investors may access the conference call at 11 a.m., ET by dialing 800-259-0251 (U.S./Canada) or 617-614-3671 (international); participant code 29191227.  An audio webcast, along with a presentation, can be accessed by logging on to the Investors & Media section under the Events tab of the Unigene web site, www.unigene.com.

A telephonic replay of the call will be available for seven days beginning at 2 p.m., ET on November 9. Access numbers for this replay are 888-286-8010 (U.S./Canada) and 617-801-6888 (international); participant code 44127298.  The webcast replay will remain available in the Investors section of the Unigene Laboratories web site for 30 days.

About Unigene Laboratories, Inc.Unigene Laboratories, Inc. is a leader in the design, delivery, manufacture and development of peptide-based therapeutics. The Company is building a robust portfolio of proprietary partnerships in this expanding drug class based on its Peptelligence™ platform. Peptelligence encompasses extensive intellectual property covering delivery and manufacturing technologies, unsurpassed research and development expertise, and proprietary know-how representing a genuine distinctive competence. Core Peptelligence assets include proprietary oral and nasal peptide delivery technologies, and proprietary, high-yield, scalable and reproducible E. coli-based manufacturing technologies.

Safe Harbor statements under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements, including with respect to clinical studies of our licensees. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are not guarantees of future performance a
'/>"/>

SOURCE Unigene Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Unigene to Announce Third Quarter 2011 Financial Results on November 9, 2011
2. Webcast Alert: Unigene Laboratories, Inc. (UGNE) Announces Third Quarter 2010 Earnings Conference Call
3. Sinovac Reports Positive Preliminary Phase II Clinical Trial Results for EV71 Vaccine Against Hand, Foot and Mouth Disease
4. GenVec Reports Third Quarter 2011 Financial Results
5. Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011
6. Allied Healthcare Products Reports First Quarter Loss on Sales Decline
7. ChemoCentryx Reports Clinical Efficacy for CCX354, a Novel CCR1 Inhibitor in a Phase II Study in Patients with Rheumatoid Arthritis
8. Stereotaxis Reports Third Quarter Financial Results
9. Isis Reports Financial Results and Highlights for Third Quarter 2011
10. Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update
11. Anadys Pharmaceuticals Reports Third Quarter 2011 Financial Results and Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... FRANCISCO , July 1, 2015 ... market) is expected to reach USD 49,119.2 million by ... Research, Inc. Monitoring services is expected to remain the ... of USD 1,227.5 million in 2012, and an estimated ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) , Browse ...
(Date:6/30/2015)... Scotland , July 1, 2015 ... joins Nu C ana team   ... ProTide technology to develop and commercialise a portfolio of ... Chris McGuigan as Chief Scientific Officer. ... ProTide technology. He is currently Professor of Medicinal Chemistry ...
(Date:6/30/2015)... , June 30, 2015 Velos, Inc., the ... continues to grow and add customers who receive Clinical ... the 62 CTSAs awarded by the National Institutes of ... management. This is among the largest such market shares ... in the CTSA community keeps growing as a result ...
Breaking Medicine Technology:mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 2mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 3mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 4mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 5Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 2Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 3Velos continues adding CTSA customers - 40% now use Velos products 2
... 2011 The Mobile Dog Heart Health Tour is heading ... health examinations at Dreher Dog Park. From 1 to 5 ... on-site heart screenings in a soundproof medical unit, as well ... (Photo:   http://photos.prnewswire.com/prnh/20110127/CG37759 ) Since early 2009, veterinarians ...
... Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUSD) ("Lotus" or ... of medicine and drugs in the People,s Republic of ... investor interest, the Company has obtained land price guidance ... wishes to provide additional details regarding its 2008 purchase ...
Cached Medicine Technology:Vets to Provide Free Dog Heart Checks in West Palm Beach 2Vets to Provide Free Dog Heart Checks in West Palm Beach 3Lotus Pharmaceuticals Provides Inner Mongolia Land Price Guidance from Cha You Qian Qi Government 2
(Date:7/1/2015)... ... ... Author Francesca Camp wasn’t always a steadfast supporter of plastic surgery. But just ... of the practice; a terrible car accident years ago left her injured and in need ... It ? (And What if I Do?): Answers to All Your Questions about Plastic Surgery” ...
(Date:7/1/2015)... ... 2015 , ... After conducting a nationwide executive search ... Center in Oceanside, Calif., has hired Cheryle Bernard-Shaw as chief compliance officer. ... efforts and growing a focus on risk management, Bernard-Shaw will assume her new ...
(Date:7/1/2015)... ... July 01, 2015 , ... Incentivizing the use of generic drugs ... discounts as much as 80% or 90% off the prices for the brand-name products. ... act to mitigate the financial impact of these high-cost generic drugs. The July issue ...
(Date:7/1/2015)... Beach, CA (PRWEB) , ... July 01, 2015 ... ... has returned to the Northbound team as Director of Referral Relations. , ... programs, including Northbound’s Collegebound, where she designed and implemented unique academic curriculum for ...
(Date:7/1/2015)... ... July 01, 2015 , ... The Thule Atmos X4 offers ... tested to ensure it lived up to Thule’s rigorous standards. Due to its Bi-ComponentArmor ... quality Thule owners have come to expect. , The Thule Atmos X4 ...
Breaking Medicine News(10 mins):Health News:Francesca Camp’s New Book Unmasks Plastic Surgery Advice 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 3Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 2Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 3Health News:Northbound Treatment Services Welcomes Emily Orrick as Director of Referral Relations 2
... A new study presented at the Annual Congress for Dermatological ... supplement marketed by Paris-based IsoCell Nutra, significantly increased the levels ... claim that SOD has a different mode of action to ... first discovered in 1968, it is the first antioxidant mobilized ...
... reduce the bulging girth of the abdomen in middle aged and ... who have conducted a study showed that regular practice of yoga ... years can lead to arrest of weight gain in obese people ... collected from 15,500 men and women in the age group of ...
... Asia. Foreigners often come to this side of the content ... in their own countries. ,More and more Globetrotters are ... during the monsoons. Why you may ask? Well it’s believed ... therapy is in the rainy months of June, July and ...
... in Pakistan has shown that handwashing ,with soap prevents ... lower respiratory infections. ,These two infections have ... under 5 years of age ,every year in the ... socio economic groups. ,In the current study done in ...
... after consumption of abortion pill cause concern to women consuming ... physicians regarding the latest reports of death of 5 women ... also called as Mifeprex or Mifepristone. Mifeprex is an approved ... The drug was introduced in the market five years ago. ...
... patients have died amid a strike by junior doctors at ... third day Saturday crippling medical services. ,Two patients died ... patients, mostly poor people who have come for treatment from ... real victims of the strike because there is no doctor ...
Cached Medicine News:Health News:New Supplement Found To Be Effective Against Sunburn 2Health News:Ayurvedic Therapies Cashing In On Medical Tourism 2Health News:Fresh warnings to doctors regarding abortion pill 2
... Level 1 enables hospitals ... patient monitors to a ... Our temperature monitoring disposale ... are superior in their ...
... The pause of a heartbeat. The bodys ... rhythmic breathing. These vital signs are yours ... DeRoyals line of Temperature Monitoring products helps ... information needed to provide the most comfortable ...
... a heartbeat. The bodys warmth beneath drapes. ... vital signs are yours to guard, measure, ... Temperature Monitoring products helps you do your ... provide the most comfortable and precise management ...
... The bodys warmth beneath drapes. The life-giving ... are yours to guard, measure, stabilize and ... products helps you do your job, giving ... most comfortable and precise management of your ...
Medicine Products: